Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Disrupted uromodulin trafficking is rescued by targeting TMED cargo receptors.
Journal: The Journal of clinical investigation
Published: February 22, 2024
FALCON systematically interrogates free fatty acid biology and identifies a novel mediator of lipotoxicity.
Journal: bioRxiv : the preprint server for biology
Published: March 03, 2023
A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic.
Journal: bioRxiv : the preprint server for biology
Published: July 09, 2020
A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury.
Journal: Cell reports. Medicine
Published: June 29, 2020
Targeting a Braf/Mapk pathway rescues podocyte lipid peroxidation in CoQ-deficiency kidney disease.
Journal: The Journal of clinical investigation
Published: June 15, 2020
Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy.
Journal: Cell
Published: August 06, 2018
A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models.
Journal: Science (New York, N.Y.)
Published: November 16, 2016
High-affinity accumulation of a maytansinoid in cells via weak tubulin interaction.
Journal: PloS one
Published: September 19, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026